首页> 外国专利> Method for determining the endogenous thrombin potential of plasma and blood, and also a computer for use in said method.

Method for determining the endogenous thrombin potential of plasma and blood, and also a computer for use in said method.

机译:确定血浆和血液的内源性凝血酶电位的方法,以及用于该方法的计算机。

摘要

This method shows how much and how long Thrombin has been active in the sample of blood or plasma. ETP CAN BE USED TO DETERMINE THE EFFECTIVENESS OF Antithrombotic treatment of some kind. Such determination ETP UNDERSTANDS, adding to said sample, a thrombin substrate, an activator of thrombin formation, preparation protease inhibitor and if desired a drug of analysis. Thrombin substrate CHOOSE not to consume FULLY amount of thrombin generated in the sample; TO HAVE A NUMBER OF CONVERSION proportional to the amount of thrombin substrate present; AND HAVE A PRODUCT RESULTING CONVERSION CONVERSION measurable thrombin. THE DETERMINATION OF THE QUANTITY OF PRODUCT OF CONVERSION, LEADS TO THE DETERMINATION OF ETP. SELECTING THE TRIGGER EFFECT DETERMINED IF THE MEASURED ON INTRINSIC SYSTEM OR EXEMPLARY Clots makes it possible to determine the effect of the drug being analyzed PARTIES ON DELSISTEMA clot.
机译:该方法显示凝血酶在血液或血浆样本中的活性时间为多少。可以使用ETP来确定某种抗血栓形成治疗的有效性。所述测定ETP理解,向所述样品中添加凝血酶底物,凝血酶形成的活化剂,制备蛋白酶抑制剂和如果需要的分析药物。选择凝血酶底物时,不要消耗样品中产生的凝血酶的量。具有与存在的凝血酶底物数量成正比的转换次数;并具有产品转化转化率可衡量的凝血酶。确定转化产物的数量,这对确定ETP至关重要。选择要测定的对内源性系统或示例性凝块的触发效应,可以确定被分析药物对DELSISTEMA凝块的影响。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号